Regulation of aldo-keto reductases in human diseases

39Citations
Citations of this article
82Readers
Mendeley users who have this article in their library.

Abstract

The aldo-keto reductases (AKRs) are a superfamily of NAD(P)H-linked oxidoreductases, which reduce aldehydes and ketones to their respective primary and secondary alcohols. AKR enzymes are increasingly being recognized to play an important role in the transfor-mation and detoxification of aldehydes and ketones generated during drug detoxification and xenobiotic metabolism. Many transcription factors have been identified to regulate the expression of human AKR genes, which could have profound effects on the metabolism of endogenous mediators and detoxication of chemical carcinogens. This review summarizes the current knowledge on AKR regulation by transcription factors and other mediators in human diseases. © 2012 Chen and Zhang.

Cite

CITATION STYLE

APA

Chen, W. D., & Zhang, Y. (2012). Regulation of aldo-keto reductases in human diseases. Frontiers in Pharmacology, 3 MAR. https://doi.org/10.3389/fphar.2012.00035

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free